This article is more than 5 years old. Information may no longer be current.

NASS issues coverage recommendation for MIS SI joint fusion

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SI-Bone recently announced the North American Spine Society has released its formal coverage recommendation for minimally invasive surgery of the sacroiliac joint fusion titled, “Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions,” based primarily on 19 published clinical studies of the SI-BONE iFuse implant system.

The North American Spine Society (NASS) concluded the sacroiliac joint is an established source of chronic low back and buttock pain, and the minimally invasive (MIS) fusion surgery of the sacroiliac joint (SI) procedure is an effective treatment, according to a company press release.

The organization also said the MIS-SI joint fusion procedure shows reduced pain scores and less blood loss when compared with an open fusion procedure.

SI-Bone received FDA 510(k) clearance in November 2008 for its iFuse Implant System, which is indicated for fusion for certain disorders of the SI joint. It received the CE mark for European commercialization in November of 2010, according to the press release.

Reference: www.si-bone.com.